| Mary Jo Laniewski, DO | |
|
3073 White Mountain Hwy, North Conway, NH 03860-7101 | |
| (603) 356-5461 | |
| Not Available |
| Full Name | Mary Jo Laniewski |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 3073 White Mountain Hwy, North Conway, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205918109 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 1531 (Maine) | Primary |
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982774378 PECOS PAC ID: 4587573001 Enrollment ID: O20031215000598 |
News Archive
In a study published recently in the journal Science Signaling Van Andel Research Institute (VARI) scientists demonstrate on the molecular level how the anti-malaria drug chloroquine represses inflammation, which may provide a blueprint for new strategies for treating inflammation and a multitude of autoimmune diseases such as arthritis, multiple sclerosis, and certain cancers.
Schizophrenia is a mental disorder that differs between the sexes in terms of age at onset, symptomatology, response to medication, and structural brain abnormalities. Now, a new study from the Universit- de Montr-al shows that there is gender difference between men and women's mental ability with women performing better than men.
Guided Therapeutics, Inc., developer of a rapid and painless biophotonic testing platform for the early detection of cancer, today announced that, after a series of meetings with the U.S. Food and Drug Administration (FDA), and after reviewing draft responses, the FDA has asked the company to provide additional information in the company's response to one remaining question.
Optimer Pharmaceuticals, Inc. announced that additional data related to fidaxomicin, the Company's lead developmental product candidate for the treatment of Clostridium difficile infection, will be presented at the 47th Annual Meeting of the Infectious Disease Society of America (IDSA) to be held at The Philadelphia Convention Center in Philadelphia, Pennsylvania October 29 through November 1, 2009.
SNM applauds a move by the U.S. Department of Energy's National Nuclear Security Administration (NNSA) to help fund the development of a domestic supply of radioisotopes, which are used to help millions of patients each year through the diagnosis and staging of cancer, thyroid and heart disease.
› Verified 7 days ago
| Entity Name | Peacehealth Medical Group Cottage Grove |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780631267 PECOS PAC ID: 9436060530 Enrollment ID: O20040616001333 |
News Archive
In a study published recently in the journal Science Signaling Van Andel Research Institute (VARI) scientists demonstrate on the molecular level how the anti-malaria drug chloroquine represses inflammation, which may provide a blueprint for new strategies for treating inflammation and a multitude of autoimmune diseases such as arthritis, multiple sclerosis, and certain cancers.
Schizophrenia is a mental disorder that differs between the sexes in terms of age at onset, symptomatology, response to medication, and structural brain abnormalities. Now, a new study from the Universit- de Montr-al shows that there is gender difference between men and women's mental ability with women performing better than men.
Guided Therapeutics, Inc., developer of a rapid and painless biophotonic testing platform for the early detection of cancer, today announced that, after a series of meetings with the U.S. Food and Drug Administration (FDA), and after reviewing draft responses, the FDA has asked the company to provide additional information in the company's response to one remaining question.
Optimer Pharmaceuticals, Inc. announced that additional data related to fidaxomicin, the Company's lead developmental product candidate for the treatment of Clostridium difficile infection, will be presented at the 47th Annual Meeting of the Infectious Disease Society of America (IDSA) to be held at The Philadelphia Convention Center in Philadelphia, Pennsylvania October 29 through November 1, 2009.
SNM applauds a move by the U.S. Department of Energy's National Nuclear Security Administration (NNSA) to help fund the development of a domestic supply of radioisotopes, which are used to help millions of patients each year through the diagnosis and staging of cancer, thyroid and heart disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Jo Laniewski, DO Po Box 5001, North Conway, NH 03860-5001 Ph: (603) 356-5461 | Mary Jo Laniewski, DO 3073 White Mountain Hwy, North Conway, NH 03860-7101 Ph: (603) 356-5461 |
News Archive
In a study published recently in the journal Science Signaling Van Andel Research Institute (VARI) scientists demonstrate on the molecular level how the anti-malaria drug chloroquine represses inflammation, which may provide a blueprint for new strategies for treating inflammation and a multitude of autoimmune diseases such as arthritis, multiple sclerosis, and certain cancers.
Schizophrenia is a mental disorder that differs between the sexes in terms of age at onset, symptomatology, response to medication, and structural brain abnormalities. Now, a new study from the Universit- de Montr-al shows that there is gender difference between men and women's mental ability with women performing better than men.
Guided Therapeutics, Inc., developer of a rapid and painless biophotonic testing platform for the early detection of cancer, today announced that, after a series of meetings with the U.S. Food and Drug Administration (FDA), and after reviewing draft responses, the FDA has asked the company to provide additional information in the company's response to one remaining question.
Optimer Pharmaceuticals, Inc. announced that additional data related to fidaxomicin, the Company's lead developmental product candidate for the treatment of Clostridium difficile infection, will be presented at the 47th Annual Meeting of the Infectious Disease Society of America (IDSA) to be held at The Philadelphia Convention Center in Philadelphia, Pennsylvania October 29 through November 1, 2009.
SNM applauds a move by the U.S. Department of Energy's National Nuclear Security Administration (NNSA) to help fund the development of a domestic supply of radioisotopes, which are used to help millions of patients each year through the diagnosis and staging of cancer, thyroid and heart disease.
› Verified 7 days ago
John F. Conlon, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3073 White Mountain Hwy, North Conway, NH 03860 Phone: 603-356-5461 | |
Richard P. Noonan, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3073 White Mountain Hwy, North Conway, NH 03860 Phone: 603-356-5461 | |
Jonathan H. Burroughs, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3073 White Mountain Hwy, North Conway, NH 03860 Phone: 603-356-5461 | |
Joseph Rc Williams, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3073 White Mountain Hwy, North Conway, NH 03860 Phone: 603-356-5461 | |
Arlene F Mrozowski, D.O Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3073 White Mountain Hwy, North Conway, NH 03860 Phone: 603-356-5461 Fax: 603-356-9048 | |
Paul Cohen, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3073 White Mountain Hwy, North Conway, NH 03860 Phone: 603-356-5461 |